Extracellular Vesicles in Beta-Thalassemia: Phenotype-Specific Profiles and Potential Clinical Associations

Area of Science:

• Hematology
• Genetics
• Cell Biology

Background:

• Beta-thalassemia is a prevalent genetic disorder causing ineffective erythropoiesis and severe complications.
• Extracellular vesicles (EVs) play a role in beta-thalassemia pathogenesis, but phenotype-specific differences are unclear.
• Understanding EV profiles in transfusion-dependent (TDT) versus non-transfusion-dependent (NTDT) beta-thalassemia is crucial for defining clinical outcomes.

Purpose of the Study:

• To review and define the distinct extracellular vesicle (EV) profiles in TDT and NTDT beta-thalassemia.
• To elucidate how these phenotype-specific EV differences contribute to varied clinical manifestations and complications.
• To explore the impact of splenectomy on EV profiles and thrombotic risk in beta-thalassemia patients.

Main Methods:

• Systematic review of existing literature on extracellular vesicles (EVs) in beta-thalassemia.
• Analysis of EV profiles (platelet, erythrocyte, leukocyte, endothelial cell-derived) in TDT and NTDT phenotypes.
• Correlation of EV alterations with clinical outcomes such as thrombosis, pulmonary hypertension, and organ dysfunction.

Main Results:

• Elevated levels of EVs from various cell types are observed in beta-thalassemia, with distinct patterns between TDT and NTDT.
• TDT is associated with EV profiles linked to transfusion and iron overload, while NTDT shows EVs related to ineffective erythropoiesis and hemolysis.
• Splenectomized patients exhibit higher procoagulant EVs, suggesting an increased thrombotic risk.

Conclusions:

• Phenotype-specific EV profiles in beta-thalassemia (TDT vs. NTDT) are linked to distinct disease complications.
• EVs contribute to endothelial activation, oxidative stress, and organ dysfunction in beta-thalassemia.
• Further research with rigorous study designs is needed to confirm the clinical utility of EVs in beta-thalassemia management.